0001209191-23-011285.txt : 20230221
0001209191-23-011285.hdr.sgml : 20230221
20230221171101
ACCESSION NUMBER: 0001209191-23-011285
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230216
FILED AS OF DATE: 20230221
DATE AS OF CHANGE: 20230221
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: FORD KATHLEEN
CENTRAL INDEX KEY: 0001785406
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37620
FILM NUMBER: 23649343
MAIL ADDRESS:
STREET 1: C/O KURA ONCOLOGY, INC.
STREET 2: 12730 HIGH BLUFF DRIVE, SUITE 400
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Kura Oncology, Inc.
CENTRAL INDEX KEY: 0001422143
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 611547851
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 12730 HIGH BLUFF DRIVE, SUITE 400
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
BUSINESS PHONE: (858) 500-8800
MAIL ADDRESS:
STREET 1: 12730 HIGH BLUFF DRIVE, SUITE 400
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
FORMER COMPANY:
FORMER CONFORMED NAME: ZETA ACQUISITION CORP III
DATE OF NAME CHANGE: 20071227
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2023-02-16
0
0001422143
Kura Oncology, Inc.
KURA
0001785406
FORD KATHLEEN
C/O KURA ONCOLOGY, INC.
12730 HIGH BLUFF DRIVE, SUITE 400
SAN DIEGO
CA
92130
0
1
0
0
Chief Operating Officer
Option to purchase common stock
11.99
2023-02-16
4
A
0
185000
0.00
A
2033-02-15
Common Stock
185000
185000
D
This option vests in 48 equal monthly installments commencing on the grant date.
Teresa Bair, Attorney-in-fact for Kathleen Ford
2023-02-21